18,587 articles
Daniel E. Bauer
Daniel E. Bauer is an American physician-scientist who directs the Gene Therapy Program at Dana-Farber/Boston Children's and identified the BCL11A enhancer target behind approved CRISPR sickle cell therapies.
Daniel E. Feldman
Daniel E. Feldman is a neuroscientist, Professor and Chair of Neuroscience at UC Berkeley, known for the 2005 Science review 'Map Plasticity in Somatosensory Cortex' and autism research.
Daniel E. Furst
Daniel E. Furst is an American rheumatologist and clinical pharmacologist, professor emeritus at UCLA, who pioneered placebo-controlled systemic sclerosis trials and helped develop rheumatoid arthritis response criteria.
Daniel E. Goldberg
Daniel E. Goldberg is an American malaria parasitologist and physician-scientist at Washington University in St. Louis whose work on Plasmodium falciparum protein export identified antimalarial drug targets.
Daniel E. Gottschling
Daniel E. Gottschling is an American molecular biologist and geneticist who studies cellular aging in yeast, known for telomere research and elected to the National Academy of Sciences.
Daniel E. Koshland (biochemist)
Daniel E. Koshland, Jr. (1920–2007) was an American biochemist at UC Berkeley known for the induced-fit model of enzyme action and for editing Science from 1985 to 1995.
Daniel E. Koshland, Jr.
Daniel E. Koshland, Jr. was a biochemist who proposed the induced fit theory of enzyme action in 1958 and the sequential KNF model of cooperativity in 1966.
Daniel E. Lieberman
Daniel E. Lieberman, born 1964, is an American paleoanthropologist and evolutionary biologist at Harvard, known for the endurance running hypothesis, the evolution of the human head, and barefoot running research.
Daniel E. Neafsey
Daniel E. Neafsey is a malaria genomics researcher at the Harvard Chan School of Public Health and the Broad Institute, known for genetic analyses of the RTS,S malaria vaccine.
Daniel E. Singer
Daniel E. Singer is an American physician-scientist at Massachusetts General Hospital and Harvard whose research on anticoagulation in atrial fibrillation set the standard INR target range.
Daniel F. Bowen‐Pope
Daniel F. Bowen-Pope is an American molecular and vascular biologist, Professor Emeritus at the University of Washington, known for his work on platelet-derived growth factor.
Daníel F. Guðbjartsson
Daníel F. Guðbjartsson (Daniel F. Gudbjartsson) is an Icelandic geneticist who has worked at deCODE genetics in Reykjavík since 1998 and was appointed head of the company in 2026.
Daniel F. Hanley
Daniel F. Hanley, also published as Daniel Hanley, is an American neurologist at Johns Hopkins who leads large randomized clinical trials in brain injury, intracerebral hemorrhage, and COVID-19 convalescent plasma.
Daniel F. Hayes
Daniel F. Hayes is an American medical oncologist and breast cancer biomarker researcher at the University of Michigan, and was President of ASCO from 2016 to 2017.
Daniel F. Klessig
Daniel F. Klessig is a plant molecular biologist who helped discover RNA splicing in adenoviruses and established salicylic acid as a key hormone in plant immunity.
Daniel F. McAuley
Daniel F. McAuley is a Professor of Intensive Care Medicine at Queen's University Belfast and the Royal Victoria Hospital, known for precision-medicine research in acute respiratory distress syndrome.
Daniel F. Voytas
Daniel F. Voytas, also known as Daniel Voytas, is an American plant geneticist at the University of Minnesota known for developing TALENs and co-founding the gene-editing company Calyxt.
Daniel Finley
Daniel Finley is an American cell biologist and Professor of Cell Biology at Harvard Medical School since 1988, known for his work on the ubiquitin-proteasome system.
Daniel Friedman (American neurologist)
Daniel Friedman is an American neurologist and epileptologist, Professor of Neurology at NYU Grossman School of Medicine, who directs the Division of Epilepsy at NYU Langone and researches cannabinoids, seizure-detection wearables, and SUDEP.
Daniel G. Bichet
Daniel G. Bichet is a Canadian nephrologist at the Hôpital du Sacré-Cœur de Montréal and Université de Montréal, first to identify the AVPR2 gene behind nephrogenic diabetes insipidus.
Daniel G. Streicker
Daniel G. Streicker is a disease ecologist and Professor of Viral Ecology at the University of Glasgow, known for his long-term research on rabies in vampire bats in Peru.
Daniel G. Tenen
Daniel G. Tenen is a hematologist-oncologist and cancer researcher, Professor of Medicine at Harvard Medical School in Boston, known for work on PU.1, C/EBPα, and SALL4 in leukemia.
Daniel Gallie
Daniel R. Gallie (1957–2020) was an American plant molecular biologist and biochemist at UC Riverside who showed that the cap and poly(A) tail of mRNA act synergistically in translation.
Daniel Gaudet
Daniel Gaudet is a Canadian lipidologist, associate professor of medicine at the Université de Montréal, and head of ECOGENE-21, known internationally for trials of APOC3-targeting drugs that lower triglycerides.
Daniel Gerlich
Daniel W. Gerlich is an Austrian-based molecular cell biologist and senior group leader at IMBA in Vienna since 2012, known for live imaging of mitotic chromosome segregation.
Daniel Goldman (neuroscientist)
Daniel Goldman is a molecular biologist and neuroscientist at the University of Michigan Medical School, where he studies how zebrafish regenerate the retina and optic nerve after injury.
Daniel H. Geschwind
Daniel H. Geschwind is an American neurologist and human geneticist at UCLA who pioneered gene co-expression network analysis defining the molecular pathology of autism and dementia.
Daniel H. Janzen
Daniel H. Janzen (born 1939) is an American tropical ecologist known for work on plant–animal interactions and for building Área de Conservación Guanacaste in Costa Rica.
Daniel H. Lowenstein
Daniel H. Lowenstein is an American neurologist and epileptologist at the University of California, San Francisco, known for research on status epilepticus, large-scale epilepsy genetics programs, and medical education reform.
Daniel H. Solomon
Daniel H. Solomon is a rheumatologist and pharmacoepidemiologist at Brigham and Women's Hospital in Boston, a Harvard Medical School professor known for research on cardiovascular risk in rheumatoid arthritis.